Characterization of Pre-operative Anemia in Patients Undergoing Surgery by a Gynecologic Oncologist and Association with Post-operative Complications
Overview
Oncology
Authors
Affiliations
Objective: Anemia is prevalent in patients with gynecologic cancers and is associated with increased peri-operative morbidity. We aimed to characterize risk factors for pre-operative anemia and describe outcomes among patients undergoing surgery by a gynecologic oncologist to identify potential areas for impactful intervention.
Methods: We analyzed major surgical cases performed by a gynecologic oncologist in the National Surgical Quality Improvement Program (NSQIP) database from 2014 to 2019. Anemia was defined as hematocrit <36%. Demographic characteristics and peri-operative variables for patients with and without anemia were compared using bivariable tests. Odds of peri-operative complications in patients stratified by pre-operative anemia were calculated using logistic regression models.
Results: Among 60 017 patients undergoing surgery by a gynecologic oncologist, 23.1% had pre-operative anemia. Women with ovarian cancer had the highest rate of pre-operative anemia at 39.7%. Patients with advanced-stage cancer had a higher risk of anemia than early-stage disease (42.0% vs 16.3%, p≤0.001). In a logistic regression model adjusting for potential demographic, cancer-related, and surgical confounders, patients with pre-operative anemia had increased odds of infectious complications (odds ratio (OR) 1.16, 95% CI 1.07 to 1.26), thromboembolic complications (OR 1.39, 95% CI 1.15 to 1.68), and blood transfusion (OR 5.78, 95% CI 5.34 to 6.26).
Conclusions: There is a high rate of anemia in patients undergoing surgery by a gynecologic oncologist, particularly those with ovarian cancer and/or advanced malignancy. Pre-operative anemia is associated with increased odds of peri-operative complications. Interventions designed to screen for and treat anemia in this population have the potential for significant impact on surgical outcomes.
Zebalski M, Krzywon A, Nowosielski K Cancers (Basel). 2024; 16(23).
PMID: 39682218 PMC: 11640205. DOI: 10.3390/cancers16234032.
Safe to save blood in ovarian cancer surgery - time to change transfusion habits.
Norbeck A, Bengtsson J, Malander S, Asp M, Kannisto P Acta Oncol. 2024; 63:728-735.
PMID: 39319937 PMC: 11439967. DOI: 10.2340/1651-226X.2024.40435.